Sfoglia per Autore
Effects of probucol on the high density lipoprotein system in hypercholesterolaemic patients
1989 G. Franceschini, L. Calabresi, G. Chiesa, V. Vaccarino, M. Sirtori, C.R. Sirtori
MECHANISMS OF HDL REDUCTION AFTER PROBUCOL - CHANGES IN HDL SUBFRACTIONS AND INCREASED REVERSE CHOLESTERYL ESTER TRANSFER
1989 G. FRANCESCHINI, M. SIRTORI, V. VACCARINO, G. GIANFRANCESCHI, L. REZZONICO, G. CHIESA, C. SIRTORI
Plasma lipoprotein changes after treatment with pravastatin and gemfibrozil in patients with familial hypercholesterolemia
1989 G. Franceschini, M. Sirtori, V. Vaccarino, G. Gianfranceschi, G. Chiesa, C.R. Sirtori
Effects of lipid lowering agents and other treatment regimens on serum lipoproteins
1990 C.R. Sirtori, G. Chiesa
In vitro activity of probucol on cholesteryl ester transport
1990 G. Chiesa, G. Franceschini, C.R. Sirtori
Efficiency and efficacy of LDL-apheresis performed at different intervals
1990 G. Franceschini, L. Calabresi, G. Chiesa, G. Busnach
Management of lipoprotein-x accumulation in severe cholestasis by semi-selective ldl-apheresis
1991 G. Franceschini, G. Busnach, G. Chiesa, C.R. Sirtori
PREDICTABILITY OF LOW-DENSITY-LIPOPROTEIN LEVELS DURING APHERETIC TREATMENT OF HYPERCHOLESTEROLEMIA
1991 G. Franceschini, G. Busnach, L. Calabresi, G. Chiesa, G. Gianfranceschi, F. Zoppi, L. Minetti, C. Sirtori
Impaired efficacy of selective LDL-apheresis in primary biliary cirrhosis
1991 G. Busnach, G. Franceschini, G. Chiesa, B. Brando, A. Cappelleri, L. Isa, L. Minetti
Probucol increases cholesteryl ester transfer protein activity in hypercholesterolaemic patients
1991 G. Franceschini, G. Chiesa, C.R. Sirtori
Activity profile of gemfibrozil on the major plasma lipoprotein parameters
1992 C.R. Sirtori, G. Franceschini, G. Gianfranceschi, V. Vaccarino, G. Chiesa, P. Maderna, M. Bertoli, L. Calabresi
Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations
1992 E. Boerwinkle, C.C. Leffert, J. Lin, C. Lackner, G. Chiesa, H.H. Hobbs
Reconstitution of lipoprotein(a) by infusion of human low density lipoprotein into transgenic mice expressing human apolipoprotein(a)
1992 G. Chiesa, H.H. Hobbs, M.L. Koschinsky, R. M. Lawn, S.D. Maika, R.E. Hammer
Atherogenesis in transgenic mice expressing human apolipoprotein(a)
1992 R.M. Lawn, D.P. Wade, R.E. Hammer, G. Chiesa, J.G. Verstuyft, E.M. Rubin
Mechanisms of high-density lipoprotein reduction after probucol treatment: Changes in plasma cholesterol esterification/transfer and lipase-activities
1993 G. Chiesa, S. Michelagnoli, M. Cassinotti, G. Gianfranceschi, J. Werba, F. Pazzucconi, C.R. Sirtori, G. Franceschini
Drugs affecting reverse cholesterol transport
1993 G. Franceschini, G. Chiesa, L. Calabresi, C.R. Sirtori
Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a)
1993 M.F. Linton, R.V. Farese, G. Chiesa, D.S. Grass, P. Chin, R.E. Hammer, H.H. Hobbs, S.G. Young
Sequence polymorphisms in the apolipoprotein (a) gene. Evidence for dissociation between apolipoprotein(a) size and plasma lipoprotein(a) levels
1993 J.C. Cohen, G. Chiesa, H.H. Hobbs
Expression of human apolipoprotein B100 in transgenic mice. Editing of human apolipoprotein B100 mRNA
1993 G. Chiesa, D.F. Johnson, Z. Yao, T.L. Innerarity, R.W. Mahley, S.G. Young, R.H. Hammer, H.H. Hobbs
Analysis of mice expressing human apo(a) and apo B-100 transgenes
1994 H.H. Hobbs, F. Mancini, G. Chiesa, V. Mooser, R. Hammer
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile